FDC gets final nod for Cefixime 400 mg Tablets

18 Dec 2024 Evaluate

FDC has received final approval from U.S. Food and Drug Administration (USFDA) for the Company’s Abbreviated New Drug Application (ANDA) for Cefixime 400 mg Tablets.

In November 2024, FDC recalled 1,55,232 bottles of Timolol Maleate ophthalmic solution in the US market. The company recalled the affected lot due to ‘Defective Container: Unable to get the solution out of the bottle as the spike of the cap was lodged in the nozzle of the product bottle.’

FDC is among India’s leading fully integrated pharmaceutical companies.

FDC Share Price

418.45 -1.55 (-0.37%)
02-Jan-2026 12:53 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1722.00
Dr. Reddys Lab 1248.00
Cipla 1503.80
Zydus Lifesciences 914.60
Lupin 2097.40
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×